Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.
作者信息
Chan Stephen L, Chan Anthony W H
机构信息
State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
出版信息
EBioMedicine. 2015 May 22;2(6):497-8. doi: 10.1016/j.ebiom.2015.05.020. eCollection 2015 Jun.
Abstract
摘要
相似文献
1
Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.
EBioMedicine. 2015 May 22;2(6):497-8. doi: 10.1016/j.ebiom.2015.05.020. eCollection 2015 Jun.
2
Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
EBioMedicine. 2015 Apr 13;2(6):604-12. doi: 10.1016/j.ebiom.2015.04.007. eCollection 2015 Jun.
3
3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
PLoS One. 2015 Apr 13;10(4):e0124197. doi: 10.1371/journal.pone.0124197. eCollection 2015.
4
Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences.
Microbiol Immunol. 2013 Mar;57(3):179-84. doi: 10.1111/1348-0421.12025.
5
Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1.
J Infect Dis. 2011 Oct 15;204(8):1172-80. doi: 10.1093/infdis/jir501.
6
Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
Oncotarget. 2017 Apr 11;8(15):24828-24839. doi: 10.18632/oncotarget.15192.
7
Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
Tumour Biol. 2016 Feb;37(2):2547-53. doi: 10.1007/s13277-015-4074-y. Epub 2015 Sep 19.
8
Serum anti-BPAG1 autoantibody level is not a useful biomarker for cutaneous melanoma.
Melanoma Res. 2016 Feb;26(1):88-9. doi: 10.1097/CMR.0000000000000189.
9
Hepatitis C virus promotes expression of the 3β-hydroxysterol δ24-reductase through Sp1.
J Med Virol. 2012 May;84(5):733-46. doi: 10.1002/jmv.23250.
10
DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.
Medicine (Baltimore). 2018 Sep;97(39):e11830. doi: 10.1097/MD.0000000000011830.
引用本文的文献
1
DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241259780. doi: 10.1177/15330338241259780.
本文引用的文献
1
Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
EBioMedicine. 2015 Apr 13;2(6):604-12. doi: 10.1016/j.ebiom.2015.04.007. eCollection 2015 Jun.
2
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Am J Gastroenterol. 2015 Jun;110(6):836-44; quiz 845. doi: 10.1038/ajg.2015.100. Epub 2015 Apr 14.
3
Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy.
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1186-95. doi: 10.1016/j.cgh.2013.11.033. Epub 2013 Dec 7.
4
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Hepatology. 2014 Mar;59(3):986-95. doi: 10.1002/hep.26739. Epub 2014 Jan 30.
5
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.
HPB (Oxford). 2014 Apr;16(4):366-72. doi: 10.1111/hpb.12146. Epub 2013 Aug 26.
6
Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study.
PLoS One. 2011 Mar 10;6(3):e16729. doi: 10.1371/journal.pone.0016729.
7
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
Gastroenterology. 2010 Jan;138(1):136-46. doi: 10.1053/j.gastro.2009.09.007. Epub 2009 Sep 18.
8
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Clin Gastroenterol Hepatol. 2009 Jan;7(1):104-13. doi: 10.1016/j.cgh.2008.08.041. Epub 2008 Sep 17.
9
A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.
Am J Gastroenterol. 1999 Jun;94(6):1605-12. doi: 10.1111/j.1572-0241.1999.01151.x.
Zotero 插件